Publication:
Is The Value of FDG PET/CT in Evaluating Renal Metastasis Underestimated? A Case Report and Review of The Literature

dc.contributor.authorsAras, Mustafa; Dede, Fuat; Ones, Tunç; Inanır, Sabahat; Erdil, Tanju Yusuf; Turoğlu, Halil Turgut
dc.date.accessioned2022-03-14T04:29:04Z
dc.date.accessioned2026-01-11T19:22:02Z
dc.date.available2022-03-14T04:29:04Z
dc.date.issued2013
dc.description.abstractContrast-enhanced CT or MRI are used as a gold standard imaging modalities in the detection and characterization of renal masses. On the other hand, the role of FDG PET/CT in evaluating primary or metastatic cancers of the kidney is limited due to the excretion of FDG through urinary tract. We reported the FDG PET/CT of a lung cancer patient with multiple metastases in both kidneys which were missed in previous PET/CT, and underestimated on sequential diagnostic abdominal CT study. CONFLICT OF INTEREST: None declared.
dc.identifier.doi10.4274/Mirt.130
dc.identifier.issn2146-1414
dc.identifier.pubmedPMID: 24416629 PMCID: PMC3888013
dc.identifier.urihttps://hdl.handle.net/11424/238777
dc.language.isoeng
dc.relation.ispartofMolecular Imaging and Radionuclide Therapy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAkciğer tümörleri
dc.subjectbilgisayarlı tomografi
dc.subjectböbrek tümörleri
dc.subjectfluorodeoksiglukoz F18
dc.subjectpozitron emisyon tomografi
dc.titleIs The Value of FDG PET/CT in Evaluating Renal Metastasis Underestimated? A Case Report and Review of The Literature
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage112
oaire.citation.startPage109
oaire.citation.titleMolecular Imaging and Radionuclide Therapy
oaire.citation.volume3

Files